ArticleClinical parkinsonism & related disorders2026
Continuous subcutaneous foslevodopa/foscarbidopa in advanced Parkinson's disease: A clinical workflow from 50 consecutive patients at a single U.S. center.
Saar Anis et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.